- increased circulating HDL cholesterol level / IMPC
- abnormal bone mineralization / IMPC
- abnormal bone structure / IMPC
- increased lean body mass / IMPC
- increased circulating cholesterol level / IMPC
- increased circulating glucose level / IMPC
- increased total body fat amount / IMPC
- increased bone mineral content / IMPC
STOCK Fgl1tm1a(EUCOMM)Hmgu/IcsOrl
Status | Available to order |
EMMA ID | EM:07684 |
International strain name | STOCK Fgl1tm1a(EUCOMM)Hmgu/IcsOrl |
Alternative name | HEPD0540_3_F06 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Fgl1tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Fgl1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0540_3_F06. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac, wild-type C57BL/6NTac |
Stage of embryos | 8-cell |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating HDL cholesterol level / IMPC
- abnormal bone mineralization / IMPC
- increased circulating glucose level / IMPC
- increased lean body mass / IMPC
- increased total body fat amount / IMPC
- increased bone mineral content / IMPC
- abnormal bone structure / IMPC
- increased circulating cholesterol level / IMPC
MGI phenotypes (gene matching)
- increased white adipose tissue amount / MGI
- decreased circulating HDL cholesterol level / MGI
- increased body length / MGI
- increased body weight / MGI
- hyperglycemia / MGI
- hepatic steatosis / MGI
- decreased circulating free fatty acid level / MGI
- abnormal gluconeogenesis / MGI
- abnormal liver weight / MGI
- decreased circulating cholesterol level / MGI
- impaired glucose tolerance / MGI
- homeostasis/metabolism phenotype / MGI
- behavior/neurological phenotype / MGI
- abnormal brown fat cell morphology / MGI
- increased white fat cell size / MGI
- increased brown fat cell lipid droplet size / MGI
- decreased white fat cell number / MGI
- increased liver triglyceride level / MGI
- decreased respiratory quotient / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).